Fumaric Acid

Fumaric Acid

SCHEMBL4679124

CC1CNCC(C)N1C(=O)OCc1ccc(OC(F)F)cc1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR2C known ✓ P28335 2/20 0.62
HTR2A known ✓ P28223 2/20 0.35
ALDH1A1 P00352 3/20 0.41
ALKBH1 Q13686 1/20 0.37
LMNA P02545 2/20 0.37
POLB P06746 1/20 0.37
CACNA1G O43497 1/20 0.36
CACNA1H O95180 1/20 0.36
CACNA1I Q9P0X4 1/20 0.36
HCAR2 Q8TDS4 1/20 0.35
ATM Q13315 1/20 0.34
PDK1 Q15118 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK3 Q15120 1/20 0.34
PDK4 Q16654 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL7671360 1.00 HTR2C (0.62) HTR2CALDH1A1ALKBH1LMNAPOLB
SCHEMBL4680302 0.93 HTR2C (0.67) HTR2CALDH1A1ALKBH1LMNAPOLB
SCHEMBL4680300 0.93 HTR2C (0.67) HTR2CALDH1A1ALKBH1LMNAPOLB
SCHEMBL4681660 0.93 HTR2C (0.67) HTR2CALDH1A1ALKBH1LMNAPOLB
Hydrochloric Acid SCHEMBL4682488 0.92 HTR2C (0.65) HTR2CALDH1A1ALKBH1LMNAPOLB
Hydrochloric Acid SCHEMBL4682494 0.92 HTR2C (0.65) HTR2CALDH1A1ALKBH1LMNAPOLB
Fumaric Acid SCHEMBL4682023 0.89 HTR2C (0.61) HTR2CALDH1A1ALKBH1CACNA1GCACNA1H
Fumaric Acid SCHEMBL4682019 0.89 HTR2C (0.61) HTR2CALDH1A1ALKBH1CACNA1GCACNA1H
Fumaric Acid SCHEMBL4682016 0.89 HTR2C (0.61) HTR2CALDH1A1ALKBH1CACNA1GCACNA1H
Fumaric Acid SCHEMBL4678139 0.86 HTR2C (0.44) HTR2CALDH1A1ALKBH1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1343775-B1 PIPERAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-06-04 EP disclosed
US-20040235859-A1 Novel piperazine derivatives ADAMS DAVID REGINALD (GB) 2004-11-25 US disclosed
EP-1343775-A2 PIPERAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-09-17 EP disclosed
WO-2002048124-A2 PIPERAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235859-A1 Novel piperazine derivatives CYP4B1, UGT1A1, CYP1B1 HTR2C 289/4885HTR2A 443/4885ALDH1A1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.